Related Experiment Videos
Potential GM-CSF Antagonists Selected from a Peptide Phage Display Library
Wei-Gang Tang1, Xiang Gao, Fa-Yun Che
1Shanghai Institute of Biochemistry, the Chinese Academy of Sciences, Shanghai 200031, China. kyw0717@sunm.shcnc.ac.cn
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao Acta Biochimica Et Biophysica Sinica
|July 13, 2002
Summary
Researchers developed a peptide phage display method to identify granulocyte-macrophage colony-stimulating factor (GM-CSF) binders. This technique successfully selected GM-CSF binding clones for potential therapeutic and downstream processing applications.
Area of Science:
- Biotechnology and Molecular Biology
- Protein Engineering and Interactions
Background:
- Peptide phage display is a powerful tool for identifying molecular ligands, including antibodies, enzymes, and receptors.
- Selecting cytokine-binding peptides using traditional phage display is challenging due to the low affinity interactions characteristic of cytokines compared to antibodies.
Purpose of the Study:
- To develop and validate a peptide phage display strategy for isolating granulocyte-macrophage colony-stimulating factor (GM-CSF) binders.
- To explore the potential applications of identified GM-CSF binders in biotechnology and therapeutics.
Main Methods:
- Construction of a pVIII-based peptide phage display library.
- Biopanning the library against GM-CSF.
- High-throughput screening (HTS) for initial clone selection.
- Confirmation of binding clones using enzyme-linked immunosorbent assay (ELISA) and micropanning.
Main Results:
- Successful selection of several peptide clones exhibiting specific binding to GM-CSF.
- Validation of these binders through HTS, ELISA, and micropanning assays.
- Demonstration of a viable method for overcoming challenges in cytokine-binder selection via phage display.
Conclusions:
- The developed pVIII-based peptide phage display approach is effective for selecting cytokine binders like GM-CSF.
- Selected GM-CSF binders hold promise for applications in cytokine downstream processing via affinity chromatography.
- Further optimization of these binders could lead to their use as potential GM-CSF antagonists.